| 1 |  LLY•US•NYSE $881.67B·$903.02·-1.64% | | $881.67B | $903.02 | -1.64% | 2.6M | |
| 2 |  JNJ•US•NYSE $582.04B·$235.27·-0.85% | | $582.04B | $235.27 | -0.85% | 9.0M | |
| 3 |  4AB•DE•XETRA $400.45B·$204.52·-3.70% | | $400.45B | $204.52 | -3.70% | 60 | |
| 4 |  ABBV•US•NYSE $388.43B·$205.20·-1.51% | | $388.43B | $205.20 | -1.51% | 7.0M | |
| 5 |  ROGN•MX•MX $347.95B·$420.15·-7.90% | | $347.95B | $420.15 | -7.90% | - | |
| 6 |  RO•CH•SW $332.93B·$400.16·-1.93% | | $332.93B | $400.16 | -1.93% | 69.2K | |
| 7 |  ROG•CH•SW $324.13B·$407.40·-6.01% | | $324.13B | $407.40 | -6.01% | 1.1M | |
| 8 | RH Roche Holding AG Participation RHHVF•US•OTCQX $317.75B·$382.00·+0.00% | | $317.75B | $382.00 | +0.00% | 40 | |
| 9 |  AZN•SE•ST $296.15B·$185.50·-2.12% | | $296.15B | $185.50 | -2.12% | 219.8K | |
| 10 |  AZN•US•NASDAQ $294.40B·$185.78·-1.40% | | $294.40B | $185.78 | -1.40% | 1.6M | |
| 11 |  NOVN•CH•SW $294.18B·$149.24·-1.69% | | $294.18B | $149.24 | -1.69% | 3.4M | |
| 12 | AZ AZNCF•US•PINK $290.60B·$183.60·-3.32% | | $290.60B | $183.60 | -3.32% | 2.1M | |
| 13 |  ZEG•DE•XETRA $287.97B·$185.69·+0.00% | | $287.97B | $185.69 | +0.00% | - | |
| 14 |  MRK•US•NYSE $285.83B·$116.37·+1.63% | | $285.83B | $116.37 | +1.63% | 7.4M | |
| 15 | MR MRK•AT•VI $285.11B·$115.55·+0.91% | | $285.11B | $115.55 | +0.91% | 376 | |
| 16 | AM AMG•DE•XETRA $200.01B·$349.88·-1.72% | | $200.01B | $349.88 | -1.72% | 577 | |
| 17 | AM AMGN•US•NASDAQ $197.41B·$348.43·-0.87% | | $197.41B | $348.43 | -0.87% | 2.3M | |
| 18 |  GIS•DE•XETRA $182.18B·$136.65·-4.34% | | $182.18B | $136.65 | -4.34% | 3.3K | |
| 19 |  NOVO-B•DK•CO $170.69B·$36.81·-1.45% | | $170.69B | $36.81 | -1.45% | 4.4M | |
| 20 | NO NOV•DE•XETRA $169.75B·$36.80·-1.38% | | $169.75B | $36.80 | -1.38% | 158.0K | |
| 21 |  Bristol-Myers Squibb Company BMY•US•NYSE $121.60B·$57.39·-3.34% | | $121.60B | $57.39 | -3.34% | 12.0M | |
| 22 |  Bristol-Myers Squibb Company BRM•DE•XETRA $121.33B·$57.27·-3.93% | | $121.33B | $57.27 | -3.93% | 981 | |
| 23 |  SAN•FR•PA $114.69B·$89.86·+2.17% | | $114.69B | $89.86 | +2.17% | 1.8M | |
| 24 | GS GS71•DE•XETRA $108.79B·$26.36·+0.04% | | $108.79B | $26.36 | +0.04% | 65.7K | |
| 25 |  SNYN•MX•MX $108.44B·$44.90·-2.38% | | $108.44B | $44.90 | -2.38% | 6 | |
| 26 |  GLAXF•US•PINK $108.17B·$27.11·+0.86% | | $108.17B | $27.11 | +0.86% | 101 | |
| 27 |  SNW•DE•XETRA $106.62B·$89.91·+2.41% | | $106.62B | $89.91 | +2.41% | 17.3K | |
| 28 |  Chugai Pharmaceutical Co. Ltd CHGCF•US•PINK $98.34B·$53.30·-3.78% | | $98.34B | $53.30 | -3.78% | 1.1K | |
| 29 |  Chugai Pharmaceutical Co Ltd ADR CHGCY•US•PINK $96.50B·$25.98·-5.87% | | $96.50B | $25.98 | -5.87% | 27.0K | |
| 30 |  CHUGAI PHARMACEUTICAL CO.,LTD. 4519•JP $87.72B·$51.80·-4.92% | | $87.72B | $51.80 | -4.92% | 1.7M | |
| 31 |  BAYN•DE•XETRA $43.86B·$43.61·-4.53% | | $43.86B | $43.61 | -4.53% | 3.2M | |
| 32 | BA BAYRY•US•OTCQX $43.47B·$10.88·-2.42% | | $43.47B | $10.88 | -2.42% | 167.1K | |
| 33 |  DAIICHI SANKYO COMPANY,LIMITED 4568•JP $35.49B·$18.96·+3.69% | | $35.49B | $18.96 | +3.69% | 8.1M | |
| 34 | DS Daiichi Sankyo Company Limited DSKYF•US•PINK $33.56B·$17.70·-0.84% | | $33.56B | $17.70 | -0.84% | 10.1K | |
| 35 |  Daiichi Sankyo Co Ltd ADR DSNKY•US•PINK $32.62B·$19.11·+3.86% | | $32.62B | $19.11 | +3.86% | 20.4K | |
| 36 | OT OTSKF•US•PINK $32.42B·$69.59·-1.07% | | $32.42B | $69.59 | -1.07% | - | |
| 37 | 45 4578•JP $30.29B·$66.83·-1.03% | | $30.29B | $66.83 | -1.03% | 982.9K | |
| 38 |  ALPMF•US•PINK $28.82B·$16.80·+3.00% | | $28.82B | $16.80 | +3.00% | 377 | |
| 39 |  IDP•DE•XETRA $27.69B·$183.55·+0.13% | | $27.69B | $183.55 | +0.13% | 485 | |
| 40 |  BIIB•US•NASDAQ $26.89B·$183.94·+0.89% | | $26.89B | $183.94 | +0.89% | 636.2K | |
| 41 | AL ALPMY•US•PINK $26.50B·$15.73·+4.38% | | $26.50B | $15.73 | +4.38% | 2.7K | |
| 42 |  4503•JP $24.81B·$15.65·+4.35% | | $24.81B | $15.65 | +4.35% | 6.4M | |
| 43 | 60 Zhangzhou Pientzehuang Pharmaceutical Co Ltd 600436•CN•SHG $13.86B·$22.15·+0.00% | | $13.86B | $22.15 | +0.00% | 1.5M | |
| 44 |  CSPC Pharmaceutical Group Ltd 1093•HK•HK $13.50B·$1.06·-9.36% | | $13.50B | $1.06 | -9.36% | 99.2M | |
| 45 | CS CSPC Pharmaceutical Group Limited CSPCY•US•PINK $12.37B·$4.17·-8.26% | | $12.37B | $4.17 | -8.26% | 16.5K | |
| 46 | OR ORINY•US•PINK $11.55B·$41.04·+0.00% | | $11.55B | $41.04 | +0.00% | - | |
| 47 | OR ORNAV•FI•HE $11.47B·$77.88·-3.85% | | $11.47B | $77.88 | -3.85% | 5.4K | |
| 48 | OR ORNBV•FI•HE $11.43B·$77.42·-4.90% | | $11.43B | $77.42 | -4.90% | 151.6K | |
| 49 | RE REC•IT $10.94B·$52.62·+2.38% | | $10.94B | $52.62 | +2.38% | 281.3K | |
| 50 | GR GRF•ES•MC $7.94B·$10.21·-3.43% | | $7.94B | $10.21 | -3.43% | 1.5M | |